12:00 AM
 | 
Oct 06, 2008
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Quark preclinical data

QPI-1007 showed significant benefit in ocular neuroprotection vs. untreated controls in a retinal ganglion cell (RGC) death by...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >